Improving the analysis of composite endpoints in rare disease trials

Overview of attention for article published in Orphanet Journal of Rare Diseases, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

news: 1 news outlet

twitter: 7 tweeters

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 22 Mendeley

Summary News Twitter Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria

Article in European Journal Of Haematology (March 2022)

Increasing power in the analysis of responder endpoints in rheumatology: a software tutorial

Article in BMC Rheumatology (December 2021)

Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential

Article in BMC Rheumatology (July 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.